Pedestrian injuries, heart disease, and Type 2 diabetes (FOI)Pedestrian injuries, heart disease, and Type 2 diabetes (FOI)
Produced by the Freedom of Information officeAuthored by Government of Jersey and published on
22 November 2019.Prepared internally, no external costs.
Request
A
Since records began, and broken down into year by year, how many confirmed reports have there been of injuries to pedestrians involving by a motorised vehicle?
B
Since records began, and broken down into year by year, how many confirmed reports have there been of deaths of pedestrians involving by a motorised vehicle?
C
Since records began, and broken down into year by year, how many confirmed reports have there been of injuries to pedestrians by a bicycle?
D
Since records began, and broken down into year by year, how many confirmed reports have there been of death of a pedestrian by a bicycle?
E
How many deaths have there been in each of the past five years of records through heart or heart complications in Jersey?
Please break it down to the following:
110-I15 Hypertensive diseases
126-I28 Pulmonary heart disease and diseases of pulmonary circulation
I60-I69 Cerebrovascular diseases
I70-I79 Diseases of arteries, arterioles and capillaries
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
F
How many deaths have there been in each of the past five years of records through diabetes type 2 complications?
G
In each of the past five years how much has been spent of the healthcare budget on those suffering heart and heart related diseases?
H
In each of the past five years how much has been spent of the healthcare budget
on those suffering from Type 2 diabetes?
I
What is the estimated cost per year of treating a Type 2 diabetes patient?
Response
A-D
Pedestrian RTC | Injuries | Deaths |
A. Motorised Vehicle | C. Cycle | B. Motorised Vehicle | D. Cycle |
2008* | 49 | 2 | | |
2009 | 56 | 2 | | |
2010 | 46 | 0 | | |
2011 | 36 | 1 | | |
2012 | 43 | 1 | 1 | |
2013 | 48 | 2 | | |
2014 | 47 | 1 | | |
2015 | 51 | 2 | | |
2016 | 42 | 6 | 1 | |
2017 | 42 | 2 | 1 | |
2018 | 46 | 2 | | |
2019** | 30 | 4 | | |
*Records are not held prior to 2008
**Figures accurate as of 16 September 2019
E
Number of deaths, by underlying cause, are given by year below. Counts less than 5 have been suppressed and all other counts have been rounded to the nearest 5 to prevent disclosure of individuals personal information.
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
110-I15 Hypertensive diseases | 20 | 20 | 20 | 10 | - | 5 | - | 10 | 10 | 10 | 15 |
126-I28 Pulmonary heart disease and diseases of pulmonary circulation | 5 | - | - | - | - | - | - | - | - | - | - |
I60-I69 Cerebrovascular diseases | 45 | 50 | 55 | 60 | 60 | 70 | 55 | 40 | 45 | 55 | 55 |
I70-I79 Diseases of arteries, arterioles and capillaries | 20 | 25 | 30 | 15 | 10 | 10 | 10 | 15 | 10 | 15 | 5 |
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | 5 | 10 | 5 | - | 5 | - | - | - | 5 | - | - |
F
Across the time period 2007-2017, on average there were 4.6 deaths each year where the underlying cause of death was recorded as 'Type 2 diabetes mellitus, with or without complications'.
In addition, there were, on average, 7.3 deaths each year where the underlying cause of death was recorded as 'Unspecific diabetes mellitus' - where it cannot be determined from the available information whether these should be classified as Type 1 or Type 2 diabetes.
It is not possible to break the data down by each year due to the small numbers making it potentially disclosive on an annual basis. Article 25 (Personal information) of the Freedom of Information (Jersey) Law 2011 has been applied. However, the year to year variation is not statistically significantly different to what would be expected from random fluctuations.
G
Business Unit | Proportion of Business Unit expenditure | 2014 (£) | 2015 (£) | 2016 (£) | 2017 (£) | 2018 (£) |
Inflight co-ordinator | 40% | 45,629 | 49,724 | 48,502 | 51,215 | 53,699 |
Charter flights | 40% | 438,130 | 446,490 | 381,161 | 397,604 | 482,977 |
Cardiology | 100% | 517,039 | 532,835 | 525,315 | 692,353 | 856,711 |
UK referrals | | 1,181,342 | 1,411,366 | 1,791,802 | 1,437,902 | 1,245,794 |
Clinical investigations (50% of everything but cardiac appliances) | 50% | 330,242 | 358,036 | 356,250 | 382,070 | 377,229 |
Clinical investigations (cardiac appliances only) | | 213,639 | 237,438 | 215,116 | 271,164 | 228,843 |
H
It is estimated that 85% of the budget allocated to diabetes has been spent on treating Type 2 diabetes. The figures below represent the estimated costs per annum. These figures do not include the cost of inpatient hospital stays.
Year | Amount |
2014 | £825,820 |
2015 | £904,192 |
2016 | £871,920 |
2017 | £1,015,050 |
2018 | £1,188,212 |
I
Information is not recorded on a cost per patient basis. To retrieve this information would require in depth analysis of each patient’s records, therefore it is not possible to break down the costs per individual within the time restraints of the Freedom of Information (Jersey) Law 2011.
Articles applied
Article 16 A scheduled public authority may refuse to supply information if cost excessive
(1) A scheduled public authority that has been requested to supply information may refuse to supply the information if it estimates that the cost of doing so would exceed an amount determined in the manner prescribed by Regulations.
Regulation 2 (1) of the Freedom of Information (Costs) (Jersey) Regulations 2014 allows an authority to refuse a request for information where the estimated cost of dealing with the request would exceed the specified amount of the cost limit of £500. This is the estimated cost of one person spending 12.5 working hours in determining whether the department holds the information, locating, retrieving and extracting the information.
Article 25 Personal information
(1) Information is absolutely exempt information if it constitutes personal data of which the applicant is the data subject as defined in the Data Protection (Jersey) Law 2018.
(2) Information is absolutely exempt information if –
(a) it constitutes personal data of which the applicant is not the data subject as defined in the Data Protection (Jersey) Law 2018; and
(b) its supply to a member of the public would contravene any of the data protection principles, as defined in that Law.
(3) In determining for the purposes of this Article whether the lawfulness principle in Article 8(1)(a) of the Data Protection (Jersey) Law 2018 would be contravened by the disclosure of information, paragraph 5(1) of Schedule 2 to that Law (legitimate interests) is to be read as if sub-paragraph (b) (which disapplies the provision where the controller is a public authority) were omitted.